Literature DB >> 26601442

Rift Valley fever.

J T Paweska.   

Abstract

Rift Valley fever (RVF) is a mosquito-borne zoonotic viral disease affecting domestic and wild ruminants, camels and humans. The causative agent of RVF, the RVF virus (RVFV), has the capacity to cause large and severe outbreaks in animal and human populations and to cross significant natural geographic barriers. Rift Valley fever is usually inapparent in non-pregnant adult animals, but pregnant animals and newborns can be severely affected; outbreaks are characterised by a sudden onset of abortions and high neonatal mortality. The majority of human infections are subclinical or associated with moderate to severe, non-fatal, febrile illness, but some patients may develop a haemorrhagic syndrome and/or ocular and neurological lesions. In both animals and humans, the primary site of RVFV replication and tissue pathology is the liver. Outbreaks of RVF are associated with persistent high rainfalls leading to massive flooding and the emergence of large numbers of competent mosquito vectors that transmit the virus to a wide range of susceptible vertebrate species. Outbreaks of RVF have devastating economic effects on countries for which animal trade constitutes the main source of national revenue. The propensity of the virus to spread into new territories and re-emerge in traditionally endemic regions, where it causes large outbreaks in human and animal populations, presents a formidable challenge for public and veterinary health authorities. The presence of competent mosquito vectors in RVF-free countries, the wide range of mammals susceptible to the virus, altering land use, the global changes in climate, and increased animal trade and travel are some of the factors which might contribute to international spread of RVF.

Entities:  

Mesh:

Year:  2015        PMID: 26601442     DOI: 10.20506/rst.34.2.2364

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  16 in total

1.  Ultrastructural pathology of human liver in Rift Valley fever.

Authors:  Mubarak Al Shraim; Refaat Eid; Khaled Radad; Noora Saeed
Journal:  BMJ Case Rep       Date:  2016-08-02

2.  Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.

Authors:  Nicole Bracci; Cynthia de la Fuente; Sahar Saleem; Chelsea Pinkham; Aarthi Narayanan; Adolfo García-Sastre; Velmurugan Balaraman; Juergen A Richt; William Wilson; Kylene Kehn-Hall
Journal:  Virology       Date:  2022-01-07       Impact factor: 3.616

3.  Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Alessandro Broglia; Inma Aznar; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-19

4.  Rift Valley Fever - assessment of effectiveness of surveillance and control measures in the EU.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Karl Stahl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Sotiria-Eleni Antoniou; Alessandro Broglia; Josè Cortiñas Abrahantes; Sofie Dhollander; Yves Van der Stede
Journal:  EFSA J       Date:  2020-11-05

5.  Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment.

Authors:  Clazien J de Vos; Wil H G J Hennen; Herman J W van Roermund; Sofie Dhollander; Egil A J Fischer; Aline A de Koeijer
Journal:  PLoS One       Date:  2021-11-02       Impact factor: 3.240

6.  [Severe hemorrhagic forms of Rift Valley fever: about 5 cases].

Authors:  Mohamed Lemine Ould Salem; Sidi El Wafi Ould Baba; Fatimetou Zahra Fall-Malick; Boushab Mohamed Boushab; Sidi Mohamed Ghaber; Abdelwedoud Mokhtar
Journal:  Pan Afr Med J       Date:  2016-05-24

7.  Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015.

Authors:  Boushab Mohamed Boushab; Fatima Zahra Fall-Malick; Sidi El Wafi Ould Baba; Mohamed Lemine Ould Salem; Marie Roseline Darnycka Belizaire; Hamade Ledib; Mohamed Mahmoud Ould Baba Ahmed; Leonardo Kishi Basco; Hampaté Ba
Journal:  Open Forum Infect Dis       Date:  2016-09-27       Impact factor: 3.835

8.  Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.

Authors:  Gema Lorenzo; Elena López-Gil; Javier Ortego; Alejandro Brun
Journal:  Vet Res       Date:  2018-02-21       Impact factor: 3.683

9.  Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.

Authors:  Fuxun Yu; Ferdinard Adungo; Samson Limbaso Konongoi; Shingo Inoue; Rosemary Sang; Salame Ashur; Allan Ole Kwallah; Leo Uchida; Corazon C Buerano; Matilu Mwau; Yan Zha; Yingjie Nie; Kouichi Morita
Journal:  Virol J       Date:  2018-11-22       Impact factor: 4.099

10.  Emerging vector-borne diseases in dromedaries in Tunisia: West Nile, bluetongue, epizootic haemorrhagic disease and Rift Valley fever.

Authors:  Thameur B Hassine; Jihane Amdouni; Federica Monaco; Giovanni Savini; Soufien Sghaier; Imed B Selimen; Walid Chandoul; Khaled B Hamida; Salah Hammami
Journal:  Onderstepoort J Vet Res       Date:  2017-03-31       Impact factor: 1.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.